Translational Research Institute (TRI)

The TRI will provide state-of-the-art core research facilities to facilitate internationally competitive outcomes in translational and clinical research. With a focus upon the fields of cancer, trauma, infectious diseases, neuroscience, diabetes, obesity, cardiovascular disease, and women’s and children’s health, the TRI will provide researchers with ready access to facilities which would otherwise be unavailable, leading to the translation of basic biomedical discoveries into new diagnostic biomarkers and therapies. 

The facility will consolidate all research groups across HMC, and encourage collaboration and innovation through a number of cross-cutting themes such as bioinformatics, ethics, molecular imaging, functional genomics, proteomics and metabolomics, clinical imaging, clinical trials and biostatistics. 

As a key component of the Academic Health System, the TRI will facilitate HMC’s development as an internationally-recognized health research organization and the leading health research organization in the Gulf region. The TRI will complement the other major biomedical research facilities in Qatar, including state-of-the-art core research facilities established at Weill Cornell Medical College in Qatar (WCMC-Q). The institute will also host Biobank Qatar, funded by the Qatar Foundation, which will include a prospective epidemiological study on the Qatari population (in collaboration with Imperial College London) and a disease specific tissue repository.